Search

everythinglearnresearchcommunity

for

Search:↓

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Combined oral contraceptives improve skin, hormone levels, and quality of life in women with PCOS.

17-β estradiol and prednisolone may speed up hair regrowth after chemotherapy.

DHEA therapy improves pubic hair growth and psychological well-being in girls with central adrenal insufficiency.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Cyclosporin A does not change sex hormone levels.

Choose treatments for sex offenders based on individual needs, using hormonal and nonhormonal options to reduce sexual drive.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

PCPA induces hypersexual behavior in male rats regardless of age or castration status.

A six-year-old girl has early signs of puberty, needs no treatment, but requires regular check-ups for future health risks.

Green tea extract and cycling hormone treatments may help treat advanced prostate cancer.

New compounds may help treat prostate issues without affecting androgen receptors.

Testosterone pellets might work for transgender men's hormone therapy, but more research is needed.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Lifestyle changes are more effective than medication for managing PCOS-related risks.

Finasteride and levofloxacin effectively reduce chronic bacterial prostatitis severity.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

A 21-year-old male with a rare genetic disorder experienced sudden hair loss and high DHEAS levels, likely due to a condition similar to PCOS, usually seen in women.

Oral contraceptives help mild hirsutism, while flutamide and spironolactone help severe cases.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

Anti-androgen drugs can help reduce OCD symptoms, but more large-scale trials are needed to confirm their effectiveness.

Starting finasteride at age 65 and continuing until age 80 is the most cost-effective strategy for prostate cancer prevention.

Older age and prostatic hyperplasia in males increase the risk of hemorrhagic cystitis after stem cell transplantation.

Combining different treatments may be needed to effectively manage chronic prostatitis.

A man developed hair loss from testosterone treatment but improved with additional medication.